Morning-Outlook-Feature-Image

morning-outlook-5thjuly

The markets traded within a narrow range and ended nearly unchanged, pausing after Wednesday’s gains. After an initial rise, the Nifty fluctuated throughout the day and settled near its intraday lowest point at 24,302.15. Sector-wise, there was a positive trend with pharmaceuticals, IT, and automotive sectors seeing moderate gains, while FMCG and metals remained subdued. Nifty Small cap and Nifty Mid cap index outperformed the key major indices each gaining about half a percent.

Meanwhile, the broader market strength and specific sectoral buying opportunities suggest that traders should focus more on stock selection and utilize dip/consolidation to add quality names.

The investors are closely monitoring the progress of the monsoon, the forthcoming Union budget which can have potential economic implications. Recent spikes in US Treasury yields and a gradual rise in crude oil prices are affecting market trends.

Immediate support is at 24000-24150. The next upside resistance to be watched around 24350-24500.

TECHNICAL PICKS

COMPANY NAME PRICE RANGE B/S SL TARGET
SYNGENE 725 BUY 717 740
ENGINEERS INDIA 265-268 BUY 260 280
TATAMTR DVR 673-676 BUY 663 697

DERIVATIVE PICKS

Long Buildup Short Buildup
Stocks Price Price% OI % OI Stocks Price Price% OI % OI
LUPIN.24.07 Jul 1766.3 7.95 42.89 10064425 RAMCOCEM.24.07 Jul 821 -2.85 11.4 8165100
LAURUSLABS.24.07 Jul 457 4.12 3.12 16809600 BAJFINANCE.24.07 Jul 7130 -2.34 9.97 9715875
ZYDUSLIFE.24.07 Jul 1144.45 3.89 6.63 15351300 HDFCBANK.24.07 Jul 1737 -1.93 3.08 141712450
PERSISTENT.24.07 Jul 4769 3.48 0.66 2161600 BANDHANBNK.24.07 Jul 208 -1.82 11.88 113688400
LALPATHLAB.24.07 Jul 2922 3.19 5.76 1152000 ADANIENT.24.07 Jul 3152.10 -1.69 1.65 16206900
                                                                        Short Covering                                                                       Long Unwinding
Stocks Price Price% OI % OI Stocks Price Price% OI % OI
CUMMINSIND.24.07 Jul 4061 2.66 -0.17 4155000 AMBUJACEM.24.07 Jul 682.35 -1.99 -0.18 36286200
TORNTPHARM.24.07 Jul 2886.7 1.38 -1.08 1348750 ACC.24.07 Jul 2731.4 -1.81 -2.39 4977300
TCS.24.07 Jul 4020 1.12 -1.83 17635450 BPCL.24.07 Jul 304.85 -0.89 -0.65 62591400
NAVINFLUOR.24.07 Jul 3666.6 1.09 -0.99 1547700 BRITANNIA.24.07 Jul 5444.9 -0.66 -0.26 2653000
PAGEIND.24.07 Jul 38960 0.98 -0.9 177735 GRASIM.24.07 Jul 2737.5 -0.58 -2.2 6368250

TOP DELIVERY PERCENTAGE

Stocks Price %Chg Total Qty Delivery Del % % Change
Sectors Price Change % Value (Lakh)
Divi S Laboratories Limi 4544.05 -0.33 242990 437428 76.29 Nifty50 24302.15 0.06 17386.04
Shree Cements Ltd. 27523 0.51 40849 51177 74.29 Niftybank 53103.7 0.03 37954.61
Bharti Airtel Limited 1423.05 0.23 9570938 6004693 72.68 Nifty it 37725.9 1.1 26946.97
Piind 3790.8 -0.17 250912 235696 71.48 India Vix 12.86 -2.58 10.65
Infosys Limited 1650.65 1.43 8008311 5108087 70.26 Nifty Fmcg 57058.4 -0.21 40851.89
Torrent Pharma Ltd. 2870.3 1.16 318200 153320 70.24 Nifty Pharma 20192.6 1.39 14385.58
Balkrishna Ind. Ltd 3150 1.21 115820 237854 67.78 Nifty Realty 1119.5 0.51 799.66
Pidilite Industries Ltd 3097.4 -0.47 213526 273653 67.1 Nifty Auto 25366.45 0.73 18119.53
The Ramco Cements 819.3 -2.48 1439295 718023 66.37 Nifty Metal 9936.8 -0.03 7118.03
Icici Lombard General In 1827.65 -1.38 404757 954378 65.92 Nifty Media 2044.9 -0.45 1463.71

UPCOMING ECONOMIC DATA

   Domestic                                                                                                                                                  International 
INR: Foreign exchange reserve 5th July

INR :  Parliament Session (24th June, 2024 to 3rd July, 2024).

USD: Unemployment rate on 5th July

NEWS UPDATES

  • Musk’s team hasn’t made any further inquiries with officials in New Delhi after the billionaire postponed a visit to India in late April, the people said, asking not to be identified because they’re not authorised to speak publicly.

 

  • UCO Bank – Total Business Up 11.51% At ₹4.62 Lk Cr Vs ₹4.14 Lk Cr (YoY), Total Advances Up 17.78% At ₹1.94 Lk Cr Vs ₹1.64 Lk Cr (YoY), Total Deposits Up 7.39% At ₹2.68 Lk Cr Vs ₹2.50 Lk Cr (YoY)

 

  • LIC raises stake in IDFC First Bank by 0.2% to 2.68% at ₹80.63/share via private placement offer

 

  • Dredging Corporation gets maintenance contract worth ₹156.50 crore from Cochin Port Authority

 

  • Zyduslife gets tentative approval from US FDA for Azilsartan Medoxomil tablets, Azilsartan Medoxomil tablets are used to treat high blood pressure

 

Source: Moneycontrol, Economic Times,  Indian Express, Business Today, Livemint, Business Standard

BOARD MEETINGS

Company Name Purpose Meeting Date Company Name Purpose Meeting Date
ADCON General 05-Jul-24 VIVANZA General 05-Jul-24
ALEXANDER A.G.M. 05-Jul-24 VIVIMEDLAB General 05-Jul-24
ATLASCYCLE Quarterly Results 05-Jul-24 ABIRAFN A.G.M.;Final Dividend;General 06-Jul-24
CELLA General 05-Jul-24 ASTALLTD Issue Of Warrants;A.G.M. 06-Jul-24
EMERALD Quarterly Results 05-Jul-24 DATASOFT Right Issue; Preferential Issue 06-Jul-24
GDTRAGN General 05-Jul-24 ECOBOAR A.G.M.;General 06-Jul-24
GPTINFRA General 05-Jul-24 GMPL A.G.M.;General 06-Jul-24
LESHAIND Right Issue of Equity Shares 05-Jul-24 GUJTLRM Increase in Authorised Capital;General 06-Jul-24
MAGENTA Half Yearly Results;Audited Results 05-Jul-24 SADBHAV Employees Stock Option Plan;General 06-Jul-24
MODULEX Audited Results 05-Jul-24 STERPOW A.G.M.;Preferential Issue 06-Jul-24
NAGPI General;Audited Results 05-Jul-24 TRICOMFRU Quarterly Results 06-Jul-24
NAKSH Rights Issue; Preferential Issue 05-Jul-24 GARMNTMNTR Bonus issue;Increase in Authorised Capital 08-Jul-24
NIBL General 05-Jul-24 GDTRAGN Quarterly Results;General 08-Jul-24
RPEL A.G.M.;General 05-Jul-24 IMCAP Stock  Split 08-Jul-24
SOUTHERNIN General 05-Jul-24 KHOOBSURAT Quarterly Results;General 08-Jul-24
SPANDANA General 05-Jul-24 NESTLEIND Interim Dividend 08-Jul-24

CORPORATE ACTION

Company Name Ex-Date Purpose Company Name Ex-Date Purpose
3MINDIA 05-Jul-24 Final Div – Rs.160/- Spl Div 525/- MLKFOOD 05-Jul-24 Interim Dividend – Rs. – 2.50
ALLSEC 05-Jul-24 Final Dividend – Rs. – 15 NAVINFLUOR 05-Jul-24 Final Dividend – Rs. – 7
APOLLOTYRE 05-Jul-24 Final Dividend – Rs. – 6 NUCLEUS 05-Jul-24 Final Dividend – Rs. – 12.50
ARTEMISMED 05-Jul-24 Final Dividend – Rs. – 0.45 PEL 05-Jul-24 Final Dividend – Rs. – 10
ASTRAZEN 05-Jul-24 Final Dividend – Rs. – 24 REDINGTON 05-Jul-24 Dividend – Rs. – 6.20
BALKRISIND 05-Jul-24 Final Dividend – Rs. – 4 REMLIFE 05-Jul-24 Bonus issue 3:1
BHARATFORG 05-Jul-24 Final Dividend – Rs. – 6.50 REMSONSIND 05-Jul-24 Split From Rs.10/- to Rs.2/-
BIOCON 05-Jul-24 Final Dividend – Rs. – 0.50 SHRAAITECH 05-Jul-24 Final Dividend – Rs. – 0.75
DJML 05-Jul-24 Final Dividend – Rs. – 0.20 THERMAX 05-Jul-24 Dividend – Rs. – 12
DUTRON 05-Jul-24 Final Dividend – Rs. – 1.50 WELENT 05-Jul-24 Final Dividend – Rs. – 3
ESCORTS 05-Jul-24 Final Dividend – Rs. – 18 CAMS 08-Jul-24 Final Dividend – Rs. – 16.50
FUTSOL 05-Jul-24 Final Dividend – Rs. – 1 CLARA 08-Jul-24 Bonus issue 4:1
INVENTURE 05-Jul-24 Right Issue of Equity Shares ATISHAY 09-Jul-24 Final Dividend – Rs. – 1
KAYCEEI 05-Jul-24 Bonus issue 4:1 BAIDFIN 09-Jul-24 Final Dividend – Rs. – 0.10
KAYCEEI 05-Jul-24 Split From Rs.100/- to Rs.10/- DCMSHRIRAM 09-Jul-24 Final Dividend – Rs. – 2.6000
M&M 05-Jul-24 Final Dividend – Rs. – 21.10 DEEPINDS 09-Jul-24 Final Dividend – Rs. – 2.4400

Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 2014

Elite Wealth Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.

For analyst certification and other important disclosures, see the Disclosure Appendix, or go to www.elitewealth.in. Analysts employed by Elite Wealth Limited are registered/qualified as research analysts with SEBI in India.( SEBI Registration No.: INH100002300)

Disclosure Appendix

Analyst Certification (For Reports)

Kiran Tahlani, Elite Wealth Limited, kirantahlani@elitestock.com

The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.

As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:

(1) all of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and

(2) no part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the report.

For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.

Research Excerpts

This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit www.elitewealth.in.

Company-Specific Disclosures

Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting https://www.elitewealth.in, or e-mailing research@elitestock.com with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail research@elitestock.com.

Options related research:

If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at https://www.elitewealth.in

Other Disclosures

All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person.

Ownership and material conflicts of interest Disclosure

Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, board member or employee of any company in the analyst’s area of coverage.

Country Specific Disclosures

India – For private circulation only, not for sale.

Legal Entities Disclosures

Mr. Ravinder Parkash Seth is the Managing Director of Elite Wealth  Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone: 011-43035555, Facsimile: 011-22795783 and Website: www.elitewealth.in

EWL discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:

  1. Reports
  2. a) EWL or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;

(b) EWL or its associates or relatives, have no actual/beneficial ownership of one per cent. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;

(c) EWL or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;

  1. Compensation

(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;

(b) EWL or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;

(c) EWL or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;

(d) EWL  or its associates have not received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months;

(e) EWL or its associates have not received any compensation or other benefits from the subject company or third party in connection with the research report.

3 In respect of Public Appearances
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by EWL

Provided that research analyst or research entity shall not be required to make a disclosure as per sub-clauses (c), (d) and (e) of clause (ii) or sub-clauses (a) and (b) of clause (iii) to the extent such disclosure would reveal material non-public information regarding specific potential future investment banking or merchant banking or brokerage services transactions of the subject company.
(4) EWL or its proprietor has never served as an officer, director or employee of the subject company;
(5) EWL has never been engaged in market making activity for the subject company;
(6) EWL shall provide all other disclosures in research report and public appearance as specified by the Board under any other regulations.